GALILEO PHARMACEUTICALS
Galileo Pharmaceuticals, Inc. is focused on the discovery and development of small molecule therapeutics to treat metabolic diseases
Similar Organizations
Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology.
Avvinity
Avvinity was established as a Joint Venture between Horizon Discovery and Centauri Therapeutics.
Biotherapies
Biotherapies, Inc. is dedicated to the development of better cancer treatment and diagnosis.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Peptor
A biopharmaceutical company engaged in discovery and development of immunotherapeutic drugs to treat diabetes
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors.
Zenha Therapeutics
Zenha Therapeutics develops a small molecule targeting microbiome to treat chronic diseases.
More informations about "Galileo Pharmaceuticals"
GALILEO PHARMACEUTICALS, INC - CAGE.report
Apr 16, 2005 GALILEO PHARMACEUTICALS, INC DUNS 867797284 / 86-779-7284. NCAGE Code: 33VH8. GALILEO PHARMACEUTICALS INC. CAGE Code: 33VH8. GALILEO …See details»
Galileo Pharmaceuticals Inc - Company Profile and News
Galileo Pharmaceuticals, Inc. provides research and development services. The Company discovers and develops small molecule therapeutics to treat metabolic and inflammatory …See details»
Galileo Pharmaceuticals Inc Information
Galileo Pharmaceuticals, Inc. is focused on the discovery and development of small molecule therapeutics to treat metabolic diseases and other disorders mediated by inflammation. We …See details»
Galileo Pharmaceuticals - Crunchbase
Galileo Pharmaceuticals, Inc. is focused on the discovery and development of small molecule therapeutics to treat metabolic diseasesSee details»
Galileo Pharmaceuticals Company Profile | Management and
Galileo Pharmaceuticals Inc is a company that operates in the Pharmaceuticals industry. It employs 21-50 people and has $5M-$10M of revenue. Popular Searches. Galileo …See details»
Galileo Pharmaceuticals - Products, Competitors, Financials, …
About Galileo Pharmaceuticals. Galileo Pharmaceuticals is a Healthcare/Pharmaceuticals / Drugs company based in Santa Clara, California. Galileo Pharmaceuticals' investors include Adams …See details»
Galileo Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Galileo Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Drug:GLI-5021, GLI-8545, GLI-7006.See details»
Galileo Pharmaceuticals - Overview, News & Similar companies
Galileo Pharmaceuticals Inc is a company that operates in the Pharmaceuticals industry. It employs 21-50 people and has $5M-$10M of revenue. Is this data correct? View contact …See details»
Galileo Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
Explore Galileo Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 1 literature. Biomedical products. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign …See details»
Galileo Pharmaceuticals: Drug pipelines, Patents, Clinical trials
Aug 2, 2023 Explore Galileo Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 2 literature. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for …See details»
GALILEO PHARMACEUTICALS Revenue, Growth & Competitor …
Galileo Pharmaceuticals doesn't have any recent trademark applications, indicating Galileo Pharmaceuticals is focusing on its existing business rather than expanding into new products …See details»
Galileo Pharmaceuticals - Company Profile - Tracxn
Oct 11, 2024 Galileo Pharmaceuticals - Redox pathway targeting small molecule drugs for neuroinflammatory disorders. This company is not active anymore. Raised a total funding of …See details»
Galileo Pharmaceuticals, Inc. - ContactOut
Galileo Pharmaceuticals, Inc. is a biotechnology company based out of 5301 Patrick Henry Dr, Santa Clara, California, United States. Galileo Pharmaceuticals, Inc. Email Format The widely …See details»
Galileo Pharmaceuticals - Raised $31M Funding from 7 investors
Nov 29, 2024 Galileo Pharmaceuticals has raised a total funding of $31M over 1 round from 7 investors. Investors include Tekla Capital Management, Bay City Capital and 5 others. Their …See details»
Galileo Pharmaceuticals - CB Insights
Explore {Galileo Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Galileo …See details»
Galileo Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Organization. Galileo Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen …See details»
Galileo closes $31M financing - Pharmaceutical industry news | The ...
May 4, 2003 Galileo closes $31M financing 4 May 2003 Privately-held US biotechnology company Galileo Pharmaceuticals, whichis focused on drug development targeting redox …See details»
GLI-7006 - Drug Targets, Indications, Patents - Synapse - Patsnap
GLI-7006, Initially developed by Galileo Pharmaceuticals, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Nervous System Diseases,Cardiovascular Diseases. ...See details»
GLI-8545 - Drug Targets, Indications, Patents - Synapse - Patsnap
GLI-8545: a CRP inhibitors Drug, Initially developed by Galileo Pharmaceuticals, Inc., Now, its global highest R&D status is Pending, Mechanism: CRP inhibitors(C-reactive protein …See details»